Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations.
作者信息
Patrinos George P, Quinones Luis Abel, Sukasem Chonlaphat
机构信息
Laboratory of Pharmacogenomics and Individualized Therapy, Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece.
Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
出版信息
Front Pharmacol. 2023 Mar 29;14:1180487. doi: 10.3389/fphar.2023.1180487. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations.社论：药物基因组学与种族：本土及其他人群中药物基因组学生物标志物的患病率及临床意义
Front Pharmacol. 2023 Mar 29;14:1180487. doi: 10.3389/fphar.2023.1180487. eCollection 2023.
2
Pharmacogenomics and Personalized Medicine.药物基因组学与个性化医学。
Genes (Basel). 2020 Jun 22;11(6):679. doi: 10.3390/genes11060679.
3
Prioritizing pharmacogenomics implementation initiates: a survey of healthcare professionals.对药物基因组学实施举措进行优先级排序：一项针对医疗保健专业人员的调查。
Per Med. 2022 Jan;19(1):15-23. doi: 10.2217/pme-2021-0061. Epub 2021 Dec 9.
4
A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.欧洲药物基因组生物标志物谱：对临床药物基因组学的影响
PLoS One. 2016 Sep 16;11(9):e0162866. doi: 10.1371/journal.pone.0162866. eCollection 2016.
5
The Gene-Drug Duality: Exploring the Pharmacogenomics of Indigenous Populations.基因与药物的双重性：探索原住民群体的药物基因组学
Front Genet. 2021 Sep 20;12:687116. doi: 10.3389/fgene.2021.687116. eCollection 2021.
6
Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.解析主要监管机构中肿瘤临床药物基因组学指南实践的异质性。
Pharmacogenomics. 2020 Nov;21(17):1247-1264. doi: 10.2217/pgs-2020-0056. Epub 2020 Oct 30.
7
Pharmacogenomics: from cell to clinic (Part 1).药物基因组学：从细胞到临床（第 1 部分）。
Pharmacogenomics. 2014 Apr;15(5):593-9. doi: 10.2217/pgs.14.35.
8
Sketching the prevalence of pharmacogenomic biomarkers among populations for clinical pharmacogenomics.描绘临床药物基因组学中人群药物基因组学生物标志物的流行情况。
Eur J Hum Genet. 2020 Jan;28(1):1-3. doi: 10.1038/s41431-019-0499-x. Epub 2019 Sep 4.
9
Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations.药物基因组学在疼痛管理中的应用：相关基因-药物关联及临床考虑的综述。
Ann Pharmacother. 2021 Dec;55(12):1486-1501. doi: 10.1177/10600280211003875. Epub 2021 Mar 26.
10
Indo-Swiss symposium on advances in pharmacogenomic strategies for implementation of personalized medicine.中印瑞士药理学基因组学策略进展研讨会：实现个体化医疗。
Pharmacogenomics. 2021 Jan;22(2):67-71. doi: 10.2217/pgs-2020-0111. Epub 2020 Dec 11.
引用本文的文献
1
Culturally responsive strategies and practical considerations for live tissue studies in Māori participant cohorts.针对毛利族参与者群体进行活体组织研究的文化响应策略及实际考量。
Front Res Metr Anal. 2024 Nov 5;9:1468400. doi: 10.3389/frma.2024.1468400. eCollection 2024.
2
Frequency of pharmacogenomic variants affecting safety and efficacy of immunomodulators and biologics in a South Asian population from Sri Lanka.斯里兰卡南亚人群中影响免疫调节剂和生物制剂安全性和疗效的药物基因组学变异的频率。
Hum Genomics. 2024 Sep 27;18(1):107. doi: 10.1186/s40246-024-00674-w.
3
The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam.越南南部卡马西平诱发的皮肤药物不良反应的药物基因组学
Front Pharmacol. 2023 Jul 13;14:1217516. doi: 10.3389/fphar.2023.1217516. eCollection 2023.
本文引用的文献
1
Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions.应用经济评估来评估作为个性化医疗干预一部分的基因检测报销的可行性。
Front Pharmacol. 2019 Aug 2;10:830. doi: 10.3389/fphar.2019.00830. eCollection 2019.
2
Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via Pharmacogenomics.药物性史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症需要通过药物基因组学进行最佳患者分层和治疗诊断。
Annu Rev Genomics Hum Genet. 2018 Aug 31;19:329-353. doi: 10.1146/annurev-genom-083115-022324. Epub 2018 Apr 13.
3
Population pharmacogenomics: impact on public health and drug development.群体药物基因组学：对公共卫生和药物研发的影响
Pharmacogenomics. 2018 Jan;19(1):3-6. doi: 10.2217/pgs-2017-0166. Epub 2017 Dec 1.
4
Exploring public genomics data for population pharmacogenomics.探索用于群体药物基因组学的公共基因组学数据。
PLoS One. 2017 Aug 3;12(8):e0182138. doi: 10.1371/journal.pone.0182138. eCollection 2017.
5
Interethnic admixture and the evolution of Latin American populations.不同种族的融合与拉丁美洲人群的进化。
Genet Mol Biol. 2014 Mar;37(1 Suppl):151-70. doi: 10.1590/s1415-47572014000200003.
6
Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in Latin America.拉丁美洲对药物/基因对有用性的认知以及药物基因组学面临的障碍。
Curr Drug Metab. 2014 Feb;15(2):202-8. doi: 10.2174/1389200215666140202220753.
Zotero 插件